文献速递小儿眼科与斜弱视眼底病与葡萄膜炎白内障与屈光手术

视网膜母细胞瘤治疗后的儿童白内障手术:病例系列与系统综述

Pediatric Cataract Surgery Following Treatment for Retinoblastoma: A Case Series and Systematic Review.
PubMed 文献 · Am J Ophthalmol · 2022-02-13

该回顾性连续病例系列纳入2000至2020年间15例视网膜母细胞瘤治疗后发生继发性白内障并接受手术的患儿(15眼),并进行系统综述(检索到852项研究,18项符合标准,共220例患儿)。术后100%眼底可见度改善、73%视力改善;无眼内复发、眼外扩散或转移。系统综述显示眼内复发6%、保眼率91%、眼外扩散和转移均<1%。

要点

  • 视网膜母细胞瘤现代治疗(包括玻璃体腔化疗和玻璃体切除术)可导致继发性白内障。
  • 白内障术后100%眼底可见度改善、73%视力改善,但视力预后可能受多种因素限制。
  • 系统综述共220例患儿,眼内复发6%、保眼率91%、眼外扩散和转移均<1%。

核心结论

  • 视网膜母细胞瘤现代治疗(包括玻璃体腔化疗和玻璃体切除术)可导致继发性白内障。
  • 白内障手术后眼内复发风险低,眼外扩散罕见。
  • 手术可改善肿瘤可见度,但视力预后可能受多种因素限制,挑战包括生物测量受限和悬韧带病变高发。

研究设计与样本

  • 回顾性连续病例系列。
  • 纳入2000至2020年间因视网膜母细胞瘤治疗后继发性白内障接受手术的18岁以下儿童。
  • 系统综述检索Medline(OVID)、Embase、Web of Science和Cochrane数据库,检索时间从建库至2020年8月。

主要发现

  • 共纳入15例患儿15眼;视网膜母细胞瘤诊断时平均年龄12个月(中位数14,IQR 4-19)。
  • 白内障发生平均年龄39个月(中位数31,IQR 20-52),继发于多种治疗(n=7)、平坦部玻璃体切除术(n=3)、外照射放疗(n=2)、激光(n=2)和视网膜脱离(n=1)。
  • 术前平均静止间期44个月(中位数28,IQR 15-64)。
  • 一期人工晶状体植入93%、后囊切开40%、前段玻璃体切除33%。
  • 术后100%眼底可见度改善、73%视力改善;并发症包括视轴混浊(11/15)、囊膜闭锁(5/15)、悬韧带病变(3/15)。

临床怎么用

  • 视网膜母细胞瘤现代治疗(包括玻璃体腔化疗和玻璃体切除术)可导致继发性白内障,白内障术后眼内复发风险低且眼外扩散罕见。
  • 手术可改善肿瘤可见度,但视力预后可能受多种因素限制,挑战包括生物测量受限和悬韧带病变高发。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine the visual and refractive outcomes and the ocular and systemic complications of cataract surgery in eyes treated for retinoblastoma. DESIGN: Retrospective consecutive case series and systematic review. METHODS: Children <18 years of age with retinoblastoma who underwent surgery for secondary cataract between 2000 and 2020 were reviewed. Medline (OVID), Embase, Web of Science, and the Cochrane database were searched from inception to August 2020. RESULTS: A total of 15 eyes of 15 children were included. The mean age at retinoblastoma diagnosis was 12 months (median, 14; interquartile range [IQR], 4-19). Cataract developed at a mean age of 39 months (median, 31; IQR, 20-52), secondary to multiple treatments (n = 7), pars-plana vitrectomy (n = 3), external-beam radiotherapy (n = 2), laser (n = 2), and retinal detachment (n = 1). The mean preoperative quiescent interval was 44 months (median, 28; IQR, 15-64). Primary intraocular lens implantation was performed in 93%, posterior capsulotomy in 40%, and anterior vitrectomy in 33% of participants. Postoperatively, 100% had improved fundus visibility and 73% had improved vision. Complications included visual axis opacification (11 of 15), capsular phimosis (5 of 15), and zonulopathy (3 of 15). No patient developed intraocular recurrence, extraocular extension, or metastasis at a mean of 76 months (median, 78; IQR, 29-128) follow-up. The systematic review identified 852 studies, with 18 meeting inclusion criteria. Across all studies (n = 220 children), intraocular recurrence occurred in 6%, globe salvage in 91%, and extraocular extension and metastasis in <1%. CONCLUSIONS: Modern retinoblastoma therapies, including intravitreal chemotherapy and vitrectomy, cause secondary cataract. Following cataract surgery, intraocular recurrence risk is low and extraocular spread is rare. Although surgery improves tumor visualization, visual prognosis may be limited by several factors. Challenges include biometry limitations and a high incidence of zonulopathy.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Kletke SN, Mallipatna A, Mireskandari K, et al. Pediatric Cataract Surgery Following Treatment for Retinoblastoma: A Case Series and Systematic Review. Am J Ophthalmol. 2022. PMID: 35172168. doi:10.1016/j.ajo.2022.02.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。